Diseases, Conditions, Syndromes

Health expenditures considerable for asthma, COPD in U.S. workers

(HealthDay)—The annualized total medical expenditures for asthma and chronic obstructive pulmonary disease (COPD) are $7 billion and $5 billion among U.S. workers, respectively, according to research published in the July ...

Diseases, Conditions, Syndromes

New PACK training tackles common diseases in developing countries

An educational outreach training package has shown to be effective for improving management of respiratory diseases in Brazil, raising hopes it could be rolled out to treat other common, severe diseases in low- and middle-income ...

Other

AstraZeneca in $560 m deal for respiratory firm

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

Immunology

Low diversity of bacteria may increase the risk for asthma

Low gut microbial diversity in the intestines of infants can increase the risk for asthma development. These are the findings of the age 7 follow-up in a multi-year study led by researchers at Linköping University in Sweden.

page 8 from 9